推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 根據(jù)2015年1月歐洲生物技術(shù)工業(yè)協(xié)會(huì)發(fā)布的意見書“歐盟委員會(huì)批準(zhǔn)安全轉(zhuǎn)基因產(chǎn)品進(jìn)口的時(shí)機(jī)嚴(yán)重延誤，危及貿(mào)易中斷，并威脅到動(dòng)物飼料供應(yīng)”顯示，自2013年年底，歐盟委員會(huì)并沒有正式做出任何批準(zhǔn)轉(zhuǎn)基因作物進(jìn)口的決定。
截至2015年1月1日，12個(gè)經(jīng)過安全評(píng)估并投票的產(chǎn)品仍然有待歐盟委員會(huì)正式通過，它們是：孟山都的棉花MON88913、油菜MON88302、玉米NK603、大豆MON87708、大豆MON87705、油菜GT73和玉米MON87460 ;拜耳作物科學(xué)的棉花GHB614×LLCotton25、玉米T25、棉花T304-40;巴斯夫的大豆BPS-CV127-9;杜邦先鋒的大豆305423。
然而，盡管歐洲食品安全局(EFSA)已經(jīng)確認(rèn)這些產(chǎn)品與傳統(tǒng)作一樣是安全的，歐盟委員會(huì)還是在一年多的時(shí)間里暫時(shí)擱置了轉(zhuǎn)基因(GM)作物的進(jìn)口許可。目前，有58項(xiàng)轉(zhuǎn)基因進(jìn)口申請(qǐng)正在等待歐盟系統(tǒng)的批準(zhǔn)，其中18個(gè)已經(jīng)完成了EFSA的風(fēng)險(xiǎn)評(píng)估。
據(jù)意見書稱，即使是歐洲委員會(huì)及其委托研究都確認(rèn)，過分拖延GMO進(jìn)口許可導(dǎo)致的貿(mào)易混亂可能會(huì)變得更加嚴(yán)重，更加頻繁，并影響更多的產(chǎn)品。經(jīng)濟(jì)總成本將達(dá)到96億歐元。
